Roche Holding AG (LON:0TDF)

London flag London · Delayed Price · Currency is GBP · Price in USD
37.47
+1.29 (3.57%)
At close: Apr 11, 2025
21.73%
Market Cap 188.61B
Revenue (ttm) 55.00B
Net Income (ttm) 7.30B
Shares Out n/a
EPS (ttm) 9.09
PE Ratio 25.85
Forward PE n/a
Dividend 0.66 (1.77%)
Ex-Dividend Date Mar 28, 2025
Volume 680,430
Average Volume 54,474
Open 37.17
Previous Close 36.18
Day's Range 37.17 - 37.47
52-Week Range 29.35 - 41.85
Beta n/a
RSI 42.62
Earnings Date Apr 25, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn... [Read more]

Industry Pharmaceutical Preparations
Founded 1896
Employees 103,249
Stock Exchange London Stock Exchange
Ticker Symbol 0TDF
Full Company Profile

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.